Joint Filing Agreement

• Date: 04 August 2020
• Parties: YA II PN, Ltd., YA Global Investments II (U.S.), Ltd., Yorkville Advisors Global, LP, Yorkville Advisors Global II, LLC, YAII GP, LP, Yorkville Advisors GP, LLC, D-Beta One EQ, Ltd., D-Beta One Blocker EQ, Ltd., D-Beta One Growth and Opportunity Fund Offshore, LP, D-Beta One GP, LLC, Delta Beta Advisors, LP
• Section: Commercial Contracts

EXHIBIT 99.1

JOINT FILING AGREEMENT

The undersigned hereby agree that the statement on Schedule 13G with respect to the equity securities of Q Biomed, Inc. is, and any amendment

thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of

Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended. The undersigned hereby further agree that this Joint Filing

Agreement be included as an exhibit to such statement and any such amendment. The undersigned acknowledge that each shall be responsible for

the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein,

but shall not be responsible for the completeness and accuracy of the information concerning the others. This Joint Filing Agreement may be

executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

Dated: 4/8/2020

YA II PN, Ltd.

By:/s/ Troy J. Rillo, Esq. Date: 4/8/2020

Troy J. Rillo, Esq.

Chief Compliance Officer

YA Global Investments II (U.S.), Ltd.

By:/s/ Troy J. Rillo, Esq. Date: 4/8/2020

Troy J. Rillo, Esq.

Chief Compliance Officer

Yorkville Advisors Global, LP

By:Yorkville Advisors Global, LLC

Its:General Partner

By:/s/ Troy J. Rillo, Esq. Date: 4/8/2020

Troy J. Rillo, Esq.

Chief Compliance Officer

Yorkville Advisors Global II, LLC

By:/s/ Troy J. Rillo, Esq. Date: 4/8/2020

Troy J. Rillo, Esq.

Chief Compliance Officer